Roffman Miller Associates’s AbbVie ABBV Stock Holding History

Roffman Miller Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53	Closed	-$7.11K	–	79
2023 Q2	$7.11K	Buy	+53	New	+$7.77K	﹤0.01%	116
2020 Q3	–	Sell	-9,900	Closed	-$972K	–	76
2020 Q2	$972K	Buy	+9,900	New	+$872K	0.1%	73

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Roffman Miller Associates's ABBV Position: Q3 2023 in Review

Roffman Miller Associates sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 53 shares — an estimated $7.11K sold.

Roffman Miller Associates first reported a position in ABBV in Q2 2020 and held it in 2 quarters. The position peaked at $972K in Q2 2020. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Roffman Miller Associates reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
Roffman Miller Associates sold 53 AbbVie shares in Q3 2023, an estimated $7.11K.
Roffman Miller Associates first reported a position in AbbVie in Q2 2020 and held it in 2 quarters.
Roffman Miller Associates's AbbVie position peaked at $972K in Q2 2020.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Roffman Miller Associates's 13F filing for Q3 2023, filed 9 Nov 2023.